Abstract
The dissolving mixture is administered through a choledochal drain to treat postoperatively retained cholesterol gallstones. It is preparted by mixing 97.0 parts of d-limonene with 2.1 parts of polysorbate 80 and 0.9 part of sorbitan monooleate, a mixture of which may easily reach the surface of the gallstones which are wetted by bile. The d-limonene preparation was found to be safe both in laboratory experiments and clinical trials. Before applying the preparation, the usual choledochal drain must be replaced with a recently developed catheter made from epichlorohydrine rubber, which is chemically resistant to the preparation. Three cases of retained gallstones are described where the preparation was successfully used. In the fourth case treatment with the preparation was tried in lieu of surgery but was not successful due to other complications. However, some dissolution of retained stones was observed. There were no postoperative complaints in the long-term follow-up of some cases for more than 2 yr after treatment with the preparation. This procedure promises to be of value because retained cholesterol stones may be dissolved without the necessity of further surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burhenne HJ: Nonoperative retained biliary tract stone extraction—A new roentgenologic technique. Am J Roentgenol Radium Ther Nucl Med 117(2):388–399, 1973
Mahorner H, Bean WJ: Removal of a residual stone from the common bile duct without surgery. Am Surg 173:857–860, 1971
Pribram BOC, Berlin MD: New methods in gallstone surgery. Surg Gynecol Obstet 60:55–64, 1935
Best RR, Rasmussen JA, Wilson CE: Management of remaining common duct stones, by various solvents and biliary flush regimen. Arch Surg 67:839–857, 1953
Way LW, Admirand WH, Dunphy JE: Management of choledocholithiasis. Ann Surg 176:347–359, 1972
Riegel C, Ravidin IS, Johnston CG: Studies of gallbladder function VI. The absorption of bile salts and cholesterol from the bile-free gallbladder. Am J Physiol 99:656–665, 1932
Aronsohn HG, Andrews E: Experimental cholecystitis. Surg Gynecol Obstet 66:748–768, 1938
Liaw J: Experimental formation of gallstone by various methods and the changes of bile acids and fatty acids in the bile. Fukuoka Acta Medica 46:222–238, 1955
Igimi H, Ide H: Improvements in or relating to substances for use in the treatment of gallstones. Br Pat 1:343–561
Igimi H, Ide H: Gallstone solubilizer. US Pat No. 3,882,248
Tsuji M, Fujisaki Y, Arikawa Y: Studies ond-limonene as a gallstone solubilizer (II). Acute and subacute toxicities. Pharmacometrics 9(3):387–401, 1975
Tsuji M, Fujisaki Y, Arikawa Y: Studies ond-limonene as a gallstone solubilizer (III). Chronic toxicities in rats. Pharmacometrics 9(3):403–412, 1975
Tsuji M, Fujisaki Y, Arikawa Y: Studies ond-limonene as a gallstone solubilizer (IV). Chronic toxicities in dogs. Pharmacometrics 9(5):775–808, 1975
Tsuji M, Fujisaki Y, Yamachika K: Studies ond-limonene as a gallstone solubilizer (I). Pharmacodynamic studies. Pharmacometrics 8(10):1439–1459, 1974
Tsuji M, Fujisaki Y, Saita M: Studies ond-limonene as a gallstone solubilizer (VI). The pharmacological effects ofd-limonenen on the biliary and gastrointestinal system. Pharmacometrics 10(2):187–197, 1975
Noda K, Matsuda T, Ishikura Y: Synthesis of14C-labelled (+)-limonene. J Labelled Compound 10(2):309–314, 1974
Igimi H, Nishimura M, Kodama R: Studies on the metabolism ofd-limonene (d-p-metha-1,8-diene) I. The absorption, distribution, and excretion ofd-limonene in rats. Xenobiotica 4(2):77–84, 1974
Kodama R, Noda K, Ide H: Studies on the metabolism ofd-limonene (d-p-mentha-1,8-diene) II. The metabolic fate ofd-limonene in rabbits. Xenobiotica 4(2):85–96, 1974
Kodama R, Yano T, Furukawa K: Studies on the metabolism ofd-limonene (d-p-mentha-1,8-diene) IV. Isolation of characterization of new metabolites and species differences in metabolism. Xenobiotica 6(1976) in press
Ariyoshi T, Arakaki M, Ideguchi K: Studies on the metabolism ofd-limonene (d-p-mentha-1,8-diene) III. Effects ofd-limonene on the lipids and drug-metabolizing enzymes in rat livers. Xenobiotica 5(1):33–38, 1975
Nogami H, Nagai T, Suzuki A: Studies on powdered preparations XVII. Dissolution rate of sulfonamide by rotating disk method. Chem Pharm Bull 14(4)329–338, 1966
Igimi H: Fundamental studies on dissolution of cholesterol stone. Igaku Kenkyu (Acta Medica) 42(1):55–66, 1972
Earnest DE, Admirand WH: The effects of individual bile salts in cholesterol solubilization and gallstone dissolution. Gastroenterology 60:772, 1971
Ide H, Kakiuchi H, Igimi H: The CHR-catheter. Jpn Pat 48-84984
Ide H, Kakiuchi H, Saito Y: The manufacturing method of the CHR-tube. Jpn Pat 48-84985
Horioka M, Aoyama M, Kakiuchi H: Characteristics of the CHR-catheter for biliary systems. Summary of the presentation at the 94th Annual Meeting of the Japanese Pharmaceutical Society, Sendai, April 4–8, 1974
Tsuji M, Fujisaki Y, Okubo A: Studies ond-limonene as a gallstone solubilizer (V). Effects on development of rat fetuses and offsprings. Pharmacometrics 10(2):179–186, 1975
Conney AH: Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19:317, 1967
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Igimi, H., Hisatsugu, T. & Nishimura, M. The use ofd-limonene preparation as a dissolving agent of gallstones. Digest Dis Sci 21, 926–939 (1976). https://doi.org/10.1007/BF01071903
Issue Date:
DOI: https://doi.org/10.1007/BF01071903